Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice.

[1]  J. Villena,et al.  Dietary Supplementation with Lactobacilli Improves Emergency Granulopoiesis in Protein-Malnourished Mice and Enhances Respiratory Innate Immune Response , 2014, PloS one.

[2]  S. O'brien,et al.  Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia , 2014, Cancer.

[3]  T. Junt,et al.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.

[4]  J. Wingard,et al.  Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple myeloma. , 2013, Transplantation proceedings.

[5]  J. Villena,et al.  Lactobacillus rhamnosus CRL1505 enhances systemic and respiratory innate immune response in immunocompromised malnourished mice , 2013 .

[6]  P. Smolewski,et al.  New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia , 2013, ISRN oncology.

[7]  C. Huh,et al.  Lactobacillus casei HY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic t cells and macrophages , 2013, Immunopharmacology and immunotoxicology.

[8]  Yangying Sun,et al.  Antioxidant and immunomodulatory activity of selenium exopolysaccharide produced by Lactococcus lactis subsp. lactis. , 2013, Food chemistry.

[9]  R. Pötter,et al.  Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Takayuki Takahashi,et al.  Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma , 2013, Leukemia & lymphoma.

[11]  Ho-yong Lee,et al.  Lactobacillus plantarum HY7712 ameliorates cyclophosphamide-induced immunosuppression in mice. , 2013, Journal of microbiology and biotechnology.

[12]  Yuanliang Hu,et al.  Effect of epimedium polysaccharide-propolis flavone immunopotentiator on immunosuppression induced by cyclophosphamide in chickens. , 2013, Cellular immunology.

[13]  S. Ansari,et al.  Protective effects of Picrorhiza kurroa on cyclophosphamide-induced immunosuppression in mice , 2013, Pharmacognosy research.

[14]  Richard J. Jones,et al.  Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases. , 2013, American journal of blood research.

[15]  J. Villena,et al.  Stimulation of macrophages by immunobiotic Lactobacillus strains: influence beyond the intestinal tract , 2012, Microbiology and immunology.

[16]  Jianxin Lu,et al.  A polysaccharide from Sargassum fusiforme protects against immunosuppression in cyclophosphamide-treated mice. , 2012, Carbohydrate polymers.

[17]  F. Le Vacon,et al.  Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens , 2012, Journal of applied microbiology.

[18]  U. R. Kuppusamy,et al.  Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic? , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  W. Su,et al.  Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. , 2012, Journal of ethnopharmacology.

[20]  S. Alvarez,et al.  Dietary Supplementation with Probiotics Improves Hematopoiesis in Malnourished Mice , 2012, PLoS ONE.

[21]  Ji-Hong Liu,et al.  Promotion of Myelopoiesis in Myelosuppressed Mice by Ganoderma lucidum Polysaccharides , 2012, Front. Pharmacol..

[22]  Z. Dvořák,et al.  Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human Hepatocytes , 2011, Front. Pharmacol..

[23]  G. Maschmeyer,et al.  Invasive Aspergillosis , 2012, Drugs.

[24]  D. Mika,et al.  Chemoprotective and immunomodulatory effect of Acacia nilotica during cyclophosphamide induced toxicity. , 2012, Journal of experimental therapeutics & oncology.

[25]  Hui Wang,et al.  A polysaccharide from Strongylocentrotus nudus eggs protects against myelosuppression and immunosuppression in cyclophosphamide-treated mice. , 2011, International immunopharmacology.

[26]  B. Obmińska-Mrukowicz,et al.  Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice , 2011, Pharmacological reports : PR.

[27]  J. Villena,et al.  Development of a fermented goats' milk containing Lactobacillus rhamnosus: in vivo study of health benefits. , 2011, Journal of the science of food and agriculture.

[28]  J. Villena,et al.  Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice , 2011, Microbiology and immunology.

[29]  J. Villena,et al.  Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. , 2010, International journal of food microbiology.

[30]  R. Brodsky.  High-dose cyclophosphamide for autoimmunity and alloimmunity , 2010, Immunologic research.

[31]  Jeffrey N. Weiser,et al.  Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.

[32]  L. Luznik,et al.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation , 2010, Immunologic research.

[33]  M. Blaut,et al.  Recent developments and perspectives in the investigation of probiotic effects. , 2010, International journal of medical microbiology : IJMM.

[34]  I. Fichtner,et al.  Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis. , 2010, In vivo.

[35]  J. Villena,et al.  Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat‐killed Lactobacillus casei , 2009, Microbiology and immunology.

[36]  J. Villena,et al.  Lactobacillus casei addition to a repletion diet-induced early normalisation of cytokine profils during a pneumococcal infection in malnourished mice , 2008 .

[37]  G. Pier,et al.  Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination , 2008, PLoS pathogens.

[38]  M. Goodell,et al.  Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics. , 2008, Experimental hematology.

[39]  A. Ruiz-Bravo,et al.  A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice. , 2007, International journal of food microbiology.

[40]  P. Staber,et al.  Antifungal management in cancer patients , 2007, Wiener Medizinische Wochenschrift.

[41]  J. Villena,et al.  Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. , 2006, Microbes and infection.

[42]  M. de la Luz Sierra,et al.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. , 2006, Blood.

[43]  Andres F Zuluaga,et al.  Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases , 2006, BMC infectious diseases.

[44]  T. Nagasawa.  Microenvironmental niches in the bone marrow required for B-cell development , 2006, Nature Reviews Immunology.

[45]  J. Villena,et al.  Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. , 2005, The Journal of nutrition.

[46]  C. Wolf,et al.  Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse. , 2005, Cancer research.

[47]  Sungching C Glenn,et al.  Invasive Fungal Infections in Pediatric Oncology Patients: 11-Year Experience at a Single Institution , 2005, Journal of pediatric hematology/oncology.

[48]  B. Machaliński,et al.  Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony‐stimulating factor on morphology of haematopoietic organs in mice , 2005, Cell proliferation.

[49]  D. Link.  Neutrophil homeostasis , 2005, Immunologic research.

[50]  D. Hicklin,et al.  A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens , 2004, Cancer Research.

[51]  S. Rankin,et al.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. , 2003, Immunity.

[52]  Z. Xing,et al.  Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer. , 2002, Blood.

[53]  S. Biswal,et al.  The molecular effects of acrolein. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[54]  I. Guest,et al.  Drugs toxic to the bone marrow that target the stromal cells. , 2000, Immunopharmacology.

[55]  M. Geertsma,et al.  Different effect of granulocyte colony‐stimulating factor or bacterial infection on bone‐marrow cells of cyclophosphamide‐treated or irradiated mice , 1999, Immunology.